Hongbo Wu

机构：Ningbo Medical Center Lihuili Hospital, Henan Cancer Hospital

发表论文 17 篇 · 总被引 106 次 · h-index 5

代表论文

• Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) (2024 · Journal of Thoracic Oncology · 被引 40)
• Magnetic Field‐Based Non‐Destructive Testing Techniques for Battery Diagnostics (2024 · Advanced Energy Materials · 被引 23)
• More metalwork removals in patients with olecranon fracture treated by tension band wiring than plate fixation-a propensity score matching analysis (2021 · BMC Musculoskeletal Disorders · 被引 10)
• Abstract CT255: AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) + tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC) (2024 · Cancer Research · 被引 9)
• Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial (2025 · Translational Lung Cancer Research · 被引 5)
• Ultrasound therapy inhibits knee osteoarthritis progression in rabbits by activating the PPARs pathway: a pilot study (2025 · Annals of Medicine · 被引 4)